{"Title": "A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis", "Year": 2018, "Source": "EBioMedicine", "Volume": "36", "Issue": null, "Art.No": null, "PageStart": 83, "PageEnd": 91, "CitedBy": 18, "DOI": "10.1016/j.ebiom.2018.09.029", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053860444&origin=inward", "Abstract": "\u00a9 2018 The AuthorsBackground: Miltefosine has been used successfully to treat visceral leishmaniasis (VL) in India, but it was unsuccessful for VL in a clinical trial in Brazil. Methods: To identify molecular markers that predict VL treatment failure whole genome sequencing of 26 L. infantum isolates, from cured and relapsed patients allowed a GWAS analysis of SNPs, gene and chromosome copy number variations. Findings: A strong association was identified (p = 0\u00b70005) between the presence of a genetically stable L. infantum Miltefosine Sensitivity Locus (MSL), and a positive response to miltefosine treatment. The risk of treatment failure increased 9\u00b74-fold (95% CI 2\u00b711\u201353\u00b754) when an isolate did not have the MSL. The complete absence of the MSL predicted miltefosine failure with 0\u00b792 (95% CI 0\u00b765\u20130\u00b7996) sensitivity and 0\u00b778 (95% CI 0\u00b752\u20130\u00b792) specificity. A genotyping survey of L. infantum (n = 157) showed that the frequency of MSL varies in a cline from 95% in North East Brazil to <5% in the South East. The MSL was found in the genomes of all L. infantum and L. donovani sequenced isolates from the Old World (n = 671), where miltefosine can have a cure rate higher than 93%. Interpretation: Knowledge on the presence or absence of the MSL in L. infantum will allow stratification of patients prior to treatment, helping to establish better therapeutic strategies for VL treatment. Fund: CNPq, FAPES, GCRF MRC and Wellcome Trust.", "AuthorKeywords": ["Miltefosine Susceptibility Locus", "Miltefosine treatment failure", "Prognostic marker", "Visceral leishmaniasis", "Whole-genome sequencing"], "IndexKeywords": ["Antiprotozoal Agents", "Brazil", "Computational Biology", "DNA Copy Number Variations", "Genetic Markers", "Genome, Protozoan", "Genomics", "Geography", "Humans", "Leishmania infantum", "Leishmaniasis, Visceral", "Phosphorylcholine", "Quantitative Trait Loci", "Treatment Failure", "Treatment Outcome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85053860444", "SubjectAreas": [["Biochemistry, Genetics and Molecular Biology (all)", "BIOC", "1300"]], "AuthorData": {"36102384700": {"Name": "Carnielli J.B.T.", "AuthorID": "36102384700", "AffiliationID": "60016418", "AffiliationName": "Centre for Immunology and Infection, Department of Biology, University of York"}, "7006201586": {"Name": "Dietze R.", "AuthorID": "7006201586", "AffiliationID": "60066048, 60031875", "AffiliationName": "Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa"}, "57198341646": {"Name": "Forrester S.", "AuthorID": "57198341646", "AffiliationID": "60016418", "AffiliationName": "Centre for Immunology and Infection, Department of Biology, University of York"}, "7404129341": {"Name": "Brown E.", "AuthorID": "7404129341", "AffiliationID": "60016418", "AffiliationName": "Centre for Immunology and Infection, Department of Biology, University of York"}, "57203610049": {"Name": "Jeffares D.C.", "AuthorID": "57203610049", "AffiliationID": "60016418", "AffiliationName": "Centre for Immunology and Infection, Department of Biology, University of York"}, "7005613209": {"Name": "Mottram J.C.", "AuthorID": "7005613209", "AffiliationID": "60001490, 60105832", "AffiliationName": "Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow"}, "56940917500": {"Name": "Crouch K.", "AuthorID": "56940917500", "AffiliationID": "60001490, 60105832", "AffiliationName": "Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow"}, "6602989159": {"Name": "Dickens N.J.", "AuthorID": "6602989159", "AffiliationID": "60001490, 60105832", "AffiliationName": "Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow"}, "57192422859": {"Name": "Silva V.C.", "AuthorID": "57192422859", "AffiliationID": "60027064", "AffiliationName": "Laborat\u00f3rio de Pesquisas em Leishmanioses, Instituto de Doen\u00e7as Tropicais Natan Portella, Universidade Federal do Piau\u00ed"}, "7201884714": {"Name": "Costa D.L.", "AuthorID": "7201884714", "AffiliationID": "60027064", "AffiliationName": "Laborat\u00f3rio de Pesquisas em Leishmanioses, Instituto de Doen\u00e7as Tropicais Natan Portella, Universidade Federal do Piau\u00ed"}, "35516775800": {"Name": "Costa C.H.N.", "AuthorID": "35516775800", "AffiliationID": "60027064", "AffiliationName": "Laborat\u00f3rio de Pesquisas em Leishmanioses, Instituto de Doen\u00e7as Tropicais Natan Portella, Universidade Federal do Piau\u00ed"}, "7005619806": {"Name": "Carvalho S.F.G.", "AuthorID": "7005619806", "AffiliationID": "60024246", "AffiliationName": "Hospital Universit\u00e1rio Clemente de Faria, Universidade Estadual de Montes Claros"}, "35810212100": {"Name": "Damasceno J.D.", "AuthorID": "35810212100", "AffiliationID": "60008088", "AffiliationName": "Laborat\u00f3rio de Biologia Molecular de Leishmania, Faculdade de Medicina de Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo"}}}